Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Behavioral: No interventionBehavioral: Developmental DemandsBehavioral: Distress ReductionBehavioral: Fear of HypoglycemiaBehavioral: Remote Monitoring
- Registration Number
- NCT02848261
- Lead Sponsor
- Stanford University
- Brief Summary
The primary objective of this project is to examine the impact of a continuous glucose monitoring (CGM) intervention on health and psychological outcomes in young children with type 1 diabetes (T1D).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 92
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description No Intervention No intervention Serves as the control group comparator. No intervention provided. Developmental Demands Developmental Demands Provide education on using diabetes technology in various settings and formats in this age group, and increase ability for real-time problem-solving. Distress Reduction Distress Reduction Identify and reduce parent distress symptoms and worries. Provide strategies for obtaining social support. Fear of Hypoglycemia Fear of Hypoglycemia Decrease fear of hypoglycemia, particularly focusing on overnight glycemic control. Remote Monitoring Remote Monitoring Optimize the use of remote monitoring by focusing on situational demands and problem solving.
- Primary Outcome Measures
Name Time Method Time spent in blood glucose range Change over 6 months Increasingly it is recognized that the percent time spent in a target blood glucose range, which is set by the American Diabetes Association, is an important outcome. This measure will be used as a primary outcome and derived from objective data downloads.
Pediatric Quality of Life Inventory Change over 6 months This is a measure of health-related quality of life. It is used to understand the broader impact on quality of life which includes social, psychological, and health aspects of daily living.
- Secondary Outcome Measures
Name Time Method Pittsburgh Sleep Quality Index Change over 6 months This questionnaire measures the degree to which sleep is disrupted and the quality of sleep experienced by participants.
A1c Change over 6 months The hemoglobin A1c value is a biologic measure of the glycemia that is the gold standard measure of "control" of diabetes. Collected through a blood sample.
Diabetes Distress Scale Change over 6 months This measure is widely used to capture the psychological distress experienced in relation to diabetes.
Patient Health Questionnaire 9 Change over 6 months This is a widely used measure that captures depressive symptoms. It is reported by the participants.
Problem Areas in Diabetes Change over 6 months This measure captures areas that are reported as problems for people with diabetes. Participants in the study report on daily problems with diabetes via this measure.
State-Trait Anxiety Inventory Change over 6 months This is a widely used measure of anxiety symptoms. It is reported by the participant.
General and diabetes-specific technology use Change over 6 months This measure has questions on attitudes and use of various general technologies (e.g., smartphone) and diabetes devices.
Hypoglycemic Fear Survey Change over 6 months People with diabetes worry about hypoglycemia. This measure captures those worries and is reported by participants.
Hypoglycemic Confidence Questionnaire Change over 6 months Hypoglycemia needs to be managed in various daily situations. This questionnaire captures confidence of the participants in those various situations.
Glucose Monitoring System Satisfaction Survey Change over 6 months This a measure used to capture overall satisfaction with glucose monitoring devices used by participants.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (4)
Stanford University
🇺🇸Stanford, California, United States
University of South Florida
🇺🇸Tampa, Florida, United States
University of Colorado
🇺🇸Aurora, Colorado, United States
Indiana University
🇺🇸Indianapolis, Indiana, United States